Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial (Q36885846)
Jump to navigation
Jump to search
scientific article published on 15 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial |
scientific article published on 15 April 2013 |
Statements
1 reference
Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial (English)
1 reference
K C Bible
1 reference
R C Smallridge
1 reference
J A Copland
1 reference
M S Brose
1 reference
J T Wadsworth
1 reference
Y Houvras
1 reference
M E Menefee
1 reference
M H Shah
1 reference
A W Gramza
1 reference
J P Klopper
1 reference
L A Marlow
1 reference
M G Heckman
1 reference
R Von Roemeling
1 reference
15 April 2013
1 reference
1 reference
2392-2400
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference